Featured
Status
Health Topics
- Analytical, Diagnostic and Therapeutic Techniques and Equipment37 See more
- Anthropology, Education, Sociology and Social Phenomena3 See more
-
Chemicals and Drugs393
- Amino Acids, Peptides, and Proteins 102
- Biological Factors 25
- Biomedical and Dental Materials 1
- Carbohydrates 15
- Chemical Actions and Uses 63
- Complex Mixtures 31
- Enzymes and Coenzymes 11
- Heterocyclic Compounds 129
- Hormones, Hormone Substitutes, and Hormone Antagonists 31
- Inorganic Chemicals 46
- Lipids 12
- Macromolecular Substances 2
- Nucleic Acids, Nucleotides, and Nucleosides 24
- Organic Chemicals 198
- Pharmaceutical Preparations 10
- Polycyclic Compounds 62
-
Diseases853
- Bacterial Infections and Mycoses 63
- Cardiovascular Diseases 91
- Chemically-Induced Disorders 38
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities 121
- Digestive System Diseases 83
- Endocrine System Diseases 71
- Eye Diseases 15
- Female Urogenital Diseases and Pregnancy Complications 92
- Hemic and Lymphatic Diseases 114
- Immune System Diseases 121
- Male Urogenital Diseases 77
- Musculoskeletal Diseases 42
- Neoplasms 204
- Nervous System Diseases 143
- Nutritional and Metabolic Diseases 118
- Occupational Diseases 4
- Otorhinolaryngologic Diseases 19
- Parasitic Diseases 13
- Pathological Conditions, Signs and Symptoms 282
- Respiratory Tract Diseases 42
- Skin and Connective Tissue Diseases 38
- Stomatognathic Diseases 16
- Virus Diseases 64
- Wounds and Injuries 29
- Health Care5 See more
-
Phenomena and Processes54
- Psychiatry and Psychology131 See more
- Technology, Industry, Agriculture7 See more
Search Clinical Trials
Not Yet Recruiting
RIC-NEC Randomized Controlled Trial (External Link)
Background: Necrotizing enterocolitis (NEC) is a serious intestinal disease of preterm and term neonates which remains a major cause of intestinal failure, and an unsolved clinical challenge in pediatrics resulting …
Baylor Role:
Collaborator
Recruiting
Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer (External Link)
This is a Phase II trial of NEOADJUVANT FOLFIRINOX CHEMOTHERAPY WITH PEMBROLIZUMAB followed by SURGERY and Adjuvant PEMBROLIZUMAB for Patients with LOCALIZED, RESECTABLE Adenocarcinoma of the pancreas. Investigators hypothesize that …
Baylor Role:
Lead Sponsor
Recruiting
Cost-effective Analysis of Two Approximation Devices in Closure of Gastrointestinal Defects (External Link)
Closure of GI defects after endoscopic resection decreases the rate of post resection bleeding. Traditionally, standard TTS clips have been used to close GI wall defects with some success. However, …
Baylor Role:
Lead Sponsor
Recruiting
Safe Babies: Parenting Action Plan ( PAP ) (External Link)
The purpose of this project is to evaluate whether prevention education using motivational interviewing focused on promoting positive maternal mental health, coping with inconsolable crying, life stress reduction, and positive …
Baylor Role:
Lead Sponsor
Recruiting
Pediatric Dose Optimization for Seizures in Emergency Medical Services (External Link)
The Pediatric Dose Optimization for Seizures in Emergency Medical Services (PediDOSE) study is designed to improve how paramedics treat seizures in children on ambulances. Seizures are one of the most …
Baylor Role:
Lead Sponsor
Recruiting
Rett Syndrome Registry (External Link)
The Rett Syndrome Registry is a longitudinal observational study of individuals with MECP2 mutations and a diagnosis of Rett syndrome. Designed together with the IRSF Rett Syndrome Center of Excellence …
Baylor Role:
Collaborator
Recruiting
Cardiopulmonary Outcomes in Osteogenesis Imperfecta: BBD7708 (External Link)
This study is cross-sectional. At the participant's one study visit, data will be obtained at a single point in time and reflect the patients' current condition. Evaluations will include family …
Baylor Role:
Lead Sponsor
Recruiting
Clear Aligners for the Treatment of Dental Malocclusion in OI Types III and IV (External Link)
Osteogenesis imperfecta (OI) is a heritable connective tissue disorder leading to frequent fractures and bone deformities. In about 90% of individuals with OI, the disease is caused by dominant mutations …
Baylor Role:
Lead Sponsor
Recruiting
Imaging-Guided Low Intensity Focused Ultrasound (LIFU) (External Link)
The current project will investigate a novel neurostimulation approach, low intensity focused ultrasound (LIFU), which combines non-invasiveness and a sharp spatial focus in deep brain regions. This open-label early feasibility …
Baylor Role:
Lead Sponsor
Active, Not Recruiting
HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With Ependymoma (External Link)
PBTC-059 is a multicenter, Phase I and Surgical study of the treatment HER2-specific CAR T cells for patients with refractory or recurrent ependymoma. Phase I The primary objectives of the …
Baylor Role:
Collaborator